Gara Jalqabaatti › Scleroderma › Illinois › Chicago
Qorannoo klinikaalii Scleroderma Chicago, IL keessatti
Qorannoo 10 Scleroderma f Chicago fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
Namoota walitti qabaa jiraSadarkaa 3
- Northwestern University, Chicago
- The University of Chicago Medical Center, Chicago
A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis
Namoota walitti qabaa jiraSadarkaa 2
- University of Illinois Health Outpatient Care Center, Chicago
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Namoota walitti qabaa jiraSadarkaa 1
- The University of Chicago Medical Center, Chicago
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Namoota walitti qabaa jiraSadarkaa 2/3
- GSK Investigational Site, Chicago
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
Namoota walitti qabaa jiraSadarkaa 1
- Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago
Platform Clinical Study for Conquering Scleroderma
Namoota walitti qabaa jiraSadarkaa 2
- The University of Chicago Medical Center (UCMC), Chicago
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Namoota walitti qabaa jiraSadarkaa 2/3
- Northwestern Memorial Hospital, Chicago
- The University of Chicago Medical Center, Chicago
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
Namoota walitti qabaa jiraSadarkaa 1/2
- Nkarta Investigational Site, Chicago
A Study of AZD0120 in Autoimmune Diseases
Namoota walitti qabaa jiraSadarkaa 1
- Research Site, Chicago
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
Namoota walitti qabaa jiraSadarkaa 2
- aTyr Investigative Site, Chicago
- aTyr Investigative Site, Chicago
- aTyr Investigative Site, Chicago
Qorannoo Scleroderma magaalota biroo keessatti
- New York City, NYQorannoo 11
- Ann Arbor, MIQorannoo 10
- Houston, TXQorannoo 9
- Boston, MAQorannoo 7
- Los Angeles, CAQorannoo 7
- Durham, NCQorannoo 7
- New Orleans, LAQorannoo 6
- Philadelphia, PAQorannoo 6
- Baltimore, MDQorannoo 6
- Dallas, TXQorannoo 5
- Pittsburgh, PAQorannoo 5
- Miami, FLQorannoo 4
Qorannoo biroo Chicago keessatti
- Kansara Qara'a Non-Small CellQorannoo 61
- Saree OljooQorannoo 59
- Saree (Gosoota Hunda)Qorannoo 51
- Kansara MetastatikiiQorannoo 45
- Kansarii ProstateQorannoo 45
- Dhibee QaraQorannoo 41
- ObesityQorannoo 41
- Kansarii OvariiQorannoo 36
- Kansarii ColorectalQorannoo 34
- StrokeQorannoo 34
- Cufama OnneeQorannoo 31
- Baayyee UlfaataaQorannoo 29
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.